Polyclonal Rabbit anti‑Human BNC1 / Basonuclin Antibody (FITC, aa1‑30, WB) LS‑C252639
Polyclonal Rabbit anti‑Human BNC1 / Basonuclin Antibody (FITC, aa1‑30, WB) LS‑C252639
Antibody:
BNC1 / Basonuclin Rabbit anti-Human Polyclonal (aa1-30) (FITC) Antibody
Overview
Antibody:
BNC1 / Basonuclin Rabbit anti-Human Polyclonal (aa1-30) (FITC) Antibody
Specifications
Description
Basonuclin antibody LS-C252639 is an FITC-conjugated rabbit polyclonal antibody to human Basonuclin (BNC1) (aa1-30). Validated for ELISA and WB.
Target
Human BNC1 / Basonuclin
Synonyms
BNC1 | Basonuclin | Basonuclin 1 | HsT19447 | BNC | BSN1 | Zinc finger protein basonuclin
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
FITC.
Also available
Unconjugated or conjugated with
AP,
APC,
Biotin,
HRP,
PE.
Purification
Affinity purified
Specificity
This BNC1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human BNC1.
Applications
- Western blot
- ELISA
- Applications tested for the base form of this product only
Usage
The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.
Presentation
PBS, No preservatives added
Storage
Short term: store at 4°C. Long term: aliquot and store at -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
Western blot, ELISA
Species:
Human, Mouse, Rat
Applications:
Western blot
Reactivity:
Human
Range:
0.156-10 ng/ml
Reactivity:
Range:
4.94-400 pg/ml
Species:
Human
Applications:
IHC, IHC - Paraffin, Peptide Enzyme-Linked Immunosorbent Assay
Reactivity:
Human
Range:
31.2-2000 pg/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 3/21/2023